Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences
- 1 July 1995
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (7) , 645-651
- https://doi.org/10.1007/bf01254566
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Gamma probe location of111 indium-labeled B72.3: An extension of immunoscintigraphyJournal of Surgical Oncology, 1992
- Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab?? in patients suspected of ovarian cancerNuclear Medicine Communications, 1992
- MAb 170H.82Nuclear Medicine Communications, 1992
- Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localizationInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1991
- Wertigkeit der Radioimmunszintigraphie im Vergleich zur Computertomographie in der Diagnostik und Verlaufskontrolle des primären OvarialkarzinomsRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1990
- Immunoscintigraphy of ovarian endometriosis. A preliminary studyBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancerNuclear Medicine Communications, 1988
- Biodistribution, pharmacokinetics and imaging of131I-labelled OC125 in ovarian cancerInternational Journal of Cancer, 1988
- Radioimmunszintigraphie beim Ovarialkarzinom: Theoretische Grundlagen und klinische ErfahrungenArchiv für Gynäkologie, 1987